Septerna, Inc.SEPN

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$38.13
Market cap
$1.8B
P/E
—
Revenue (TTM)
$98.9M
Net income
-$24.2M
Dividend yield
—
1-year total return
127.6%
Net margin
-24.5%
Revenue growth
13520.1%
Debt / equity
—

What Septerna, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue—$151,000$1.1M$46.0M
Net income—$4.2M-$71.8M-$48.9M
Free cash flow—-$41.6M-$69.6M$109.7M

More on SEPN.

Figures from Septerna, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.